The 2024 Q3 earnings season continues at a rapid pace, with a nice variety of companies delivering quarterly results daily. So far, several popular stocks, namely Advanced Micro Devices AMD and Eli Lilly LLY – have reported quarterly results, with the two seeing negative post-earnings reactions. But did the results warrant the knee-jerk reaction? Let’s … Read more
Here Are My Top Artificial Intelligence (AI) Stocks to Buy Right Now (Hint: Nvidia's Not on the List)
Russ Cohen
Plenty of stock have ridden the boom in artificial intelligence (AI) this year. I’m going to focus on the two that make my buy list. One aspect of AI software is the huge demand for data processing power, all of which has to be housed somewhere. This is driving demand for hyperscale data centers (those … Read more
Transforming Business Through AI the Focus of ISG Digital Business Summit
Russ Cohen
November 13–15 event in Dallas will feature leaders with Keurig Dr Pepper, Johnson Controls, L’Oreal, PNC and more Leaders with Keurig Dr Pepper, Johnson Controls, L’Oreal, PNC and other companies will join the ISG Digital Business Summit, November 13–15, in Dallas to share strategies for leveraging generative AI (GenAI) and other new technologies to drive … Read more
Noteworthy Monday Option Activity: NUE, AAPL, MSFT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Nucor Corp. (Symbol: NUE), where a total of 18,714 contracts have traded so far, representing approximately 1.9 million underlying shares. That amounts to about 98.8% of NUE’s average daily trading volume over the past month of 1.9 million … Read more
Crypto Market Update: Q3 2024 in Review
A turbulent Q3 in the crypto market was marked by price volatility and shifts in investor sentiment. Popular cryptocurrency Bitcoin, often seen as a bellwether for the industry, experienced sharp price corrections at the start of each month, with July and August witnessing declines exceeding 12 percent. Meanwhile, Ethereum’s performance in Q3 showed signs of … Read more
ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit
LOS ANGELES, Oct. 31, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Allarity Therapeutics, Inc. (“Allarity” or the “Company”) ALLR. Class Period: May 17, 2022 – July 19, 2024Lead Plaintiff Deadline: November 12, 2024 If you wish … Read more